Causes and Management of Children Presenting With Macroscopic Hematuria in the Pediatric Emergency Department (HMUP)

December 30, 2025 updated by: University Hospital, Strasbourg, France

Macroscopic hematuria. is a common symptom, leading to numerous emergency department visits in children of all ages.

It can be linked to many pathologies, and its management in the emergency department is not standardized.

Few articles describe the management of this symptom during pediatric emergency department visits.

Therefore, it is important to study this symptom and its management in order to establish a protocol.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Strasbourg, France, 67091
        • Recruiting
        • Service de Pédiatrie 1 - Réanimation - CHU de Strasbourg - France
        • Contact:
        • Principal Investigator:
          • Ariane ZALOSZYC, MD, PhD
        • Principal Investigator:
          • Inès BERNHARD, MD
        • Principal Investigator:
          • Sarah DE THOMASIS, MD
        • Principal Investigator:
          • Noelle LACHAUSSEE, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Minor subject (<18 years old) presenting to the pediatric emergency department with gross hematuria

Description

Inclusion Criteria:

  • Minor subject (<18 years old)
  • Patient presenting to the pediatric emergency department with gross hematuria

Exclusion Criteria:

- Subject (and/or their parents) who expressed their opposition to participating in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Describe the different causes of this symptom
Time Frame: Up to 12 months
Up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2024

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

December 10, 2025

First Submitted That Met QC Criteria

December 30, 2025

First Posted (Actual)

December 31, 2025

Study Record Updates

Last Update Posted (Actual)

December 31, 2025

Last Update Submitted That Met QC Criteria

December 30, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 9456

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Macroscopic Hematuria

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe